BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.358
+0.014 (4.07%)
At close: Jan 21, 2025, 4:00 PM
0.360
+0.002 (0.56%)
After-hours: Jan 21, 2025, 7:37 PM EST
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $17.77 million as of January 21, 2025. Its market cap has decreased by -78.17% in one year.
Market Cap
17.77M
Enterprise Value
82.35M
1-Year Change
-78.17%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $17.77M, a decrease of -89.70%. That is a compound annual growth rate of -28.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |